Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease

Published:2020-04-19 Issue:8 Volume:22 Page:1348-1356
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Saeed Mohamad Isam¹^ORCID,Eklöf Josefin¹,Achir Imane¹,Sivapalan Pradeesh¹²,Meteran Howraman¹,Løkke Anders³,Biering‐Sørensen Tor⁴,Knop Filip Krag⁵⁶⁷⁸,Jensen Jens‐Ulrik Stæhr¹⁶⁹

Affiliation:

1. Section of Respiratory Medicine, Department of MedicineHerlev and Gentofte Hospital, University of Copenhagen Hellerup Denmark

2. Department of Internal MedicineZealand Hospital, University of Copenhagen Roskilde Denmark

3. Department of MedicineHospital Little Belt Vejle Denmark

4. Department of CardiologyHerlev and Gentofte Hospital, University of Copenhagen Hellerup Denmark

5. Center for Clinical Metabolic ResearchHerlev and Gentofte Hospital, University of Copenhagen Hellerup Denmark

6. Department of Clinical Medicine, Faculty of Health and Medical SciencesUniversity of Copenhagen Copenhagen Denmark

7. Steno Diabetes Center Copenhagen Gentofte Denmark

8. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical SciencesUniversity of Copenhagen Copenhagen Denmark

9. PERSIMUNE & CHIP: Department of Infectious Diseases, Rigshospitalet, University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14040

Reference24 articles.

1. Use of inhaled corticosteroids in COPD: improving efficacy

2. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019

3. A population based case-control study of cataract and inhaled corticosteroids

4. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts

5. The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of inhaled and intranasal corticosteroids on glucose metabolism and diabetes mellitus: A mini review;World Journal of Diabetes;2023-08-15

2. Inhaled corticosteroids and adverse outcomes among chronic obstructive pulmonary disease patients with community-acquired pneumonia: a population-based cohort study;Frontiers in Medicine;2023-07-24

3. All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD);International Journal of Chronic Obstructive Pulmonary Disease;2023-06

4. Study protocol: pneumonia and inhaled corticosteroid treatment patterns in chronic obstructive pulmonary disease – a cohort study using sequence analysis (PICCS);BMJ Open;2023-06

5. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis;Frontiers in Immunology;2023-04-11